Integrated Diagnostics Holdings Plc
Notice of Results
28 May 2024
(London) Integrated Diagnostics Holdings ("IDH," "the
Group," or "the Company"), a leading provider of diagnostic
services with operations in Egypt, Jordan, Nigeria, Sudan, and
Saudi Arabia, will
publish its audited results for the quarter ended 31 March 2024 on
Thursday, 30 May 2024 at 7am (UK).
An analyst and
investor call will be hosted at 1pm (UK) | 3pm (Egypt) on Monday, 3
June 2024. You can learn more details and register for the call by
clicking on this
link.
For more information
about the event, please contact: amoataz@EFG-HERMES.com
-Ends-
About Integrated Diagnostics Holdings (IDH)
IDH is a leading diagnostics services provider in the
Middle East and Africa offering a broad range of clinical pathology
and radiology tests to patients in Egypt, Jordan, Nigeria, Sudan,
and Saudi Arabia. The Group's core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan),
Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in
Sudan), and Biolab KSA (Saudi Arabia). With over 40 years of
experience, a long track record for quality and safety has earned
the Company a trusted reputation, as well as internationally
recognised accreditations for its portfolio of over 3,000
diagnostics tests. From its base of 601 branches as of 31 December
2023, IDH served over 8.5 million patients and performed more than
36.1 million tests in 2023. IDH will continue to add laboratories
through a Hub, Spoke and Spike business model that provides a
scalable platform for efficient expansion. Beyond organic growth,
the Group targets expansion in appealing markets, including
acquisitions in the Middle Eastern, African, and East Asian markets
where its model is well-suited to capitalise on similar healthcare
and consumer trends and capture a significant share of fragmented
markets. IDH has been a Jersey-registered entity with a Standard
Listing on the Main Market of the London Stock Exchange (ticker:
IDHC) since May 2015 with a secondary listing on the EGX since May
2021 (ticker: IDHC.CA).
The person responsible for arranging
the release of this announcement is Tarek Yehia, Investor Relations
Director at IDH.
Contact
Tarek Yehia
Investor Relations
Director
T: +20 (0)2 3332 1126 | M: +20 10
6882 6678 | tarek.yehia@idhcorp.com